SCHEMBL23608968

SCHEMBL23608968

FC(F)(F)C(Nc1ccc(NCCn2cncn2)cn1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.39
SMN1; SMN2 Q16637 5/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 2/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 2/20 0.35
LMNA P02545 3/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
TP53 P04637 2/20 0.33
CYP26A1 O43174 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
TSHR P16473 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23608954 0.79 CYP19A1 (0.51) CYP19A1KMT2AMAPK1LMNAHSP90AA1
SCHEMBL23608945 0.78 SMN1; SMN2 (0.38) CYP19A1SMN1; SMN2KMT2AALDH1A1HTT
SCHEMBL23609168 0.78 CYP19A1 (0.38) CYP19A1SMN1; SMN2ALDH1A1MAPK1HTT
SCHEMBL29972975 0.74 MAPK1 (0.38) CYP19A1SMN1; SMN2KMT2AALDH1A1MAPK1
SCHEMBL23609599 0.74 MAPK1 (0.38) CYP19A1SMN1; SMN2KMT2AALDH1A1MAPK1
SCHEMBL30406442 0.74 CYP19A1 (0.46) CYP19A1SMN1; SMN2KMT2AALDH1A1HPGD
SCHEMBL23608970 0.74 CYP19A1 (0.46) CYP19A1SMN1; SMN2KMT2AALDH1A1HPGD
SCHEMBL23875581 0.72 CYP19A1 (0.51) CYP19A1SMN1; SMN2KMT2AALDH1A1MAPK1
SCHEMBL30405846 0.71 MAPK1 (0.39) CYP19A1SMN1; SMN2KMT2AALDH1A1MAPK1
SCHEMBL23608948 0.71 GPR55 (0.47) CYP19A1SMN1; SMN2KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117592-A1 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2023-04-20 US disclosed
WO-2021133689-A2 LIPOXYGENASE INHIBITORS SRI INTERNATIONAL (US) 2021-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117592-A1 LIPOXYGENASE INHIBITORS ALOX15B, ALOX12, ALOX5 CYP19A1 153/4885SMN1; SMN2 243/4885KMT2A 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.